(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Purity ≥98.0% (HPLC) I-Rivaroxaban Intermediate Factory Featured Image

(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Purity ≥98.0% (HPLC) Rivaroxaban Intermediate Factory

Incazelo emfushane:

Igama Lekhemikhali: (S)-(+)-Glycidyl Phthalimide

I-CAS: 161596-47-0

Ukubukeka: Impushana Emhlophe ukuya Emhlophe

Ubumsulwa: ≥98.0% (HPLC)

I-Intermediate ye-Rivaroxaban (CAS: 366789-02-8) ekwelapheni i-Venous Thromboembolism (VTE)

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Umkhiqizi Okuhlobene Ne-Rivaroxaban Intermediate:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0
I-Rivaroxaban I-CAS 446292-07-5
I-5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
I-Rivaroxaban API CAS 366789-02-8

Chemical Properties:

Igama Lekhemikhali	(S)-(+)-Glycidyl Phthalimide
Omqondofana	(S)-Glycidyl Phthalimide;(S)-N-Glycidylphthalimide;I-Rivaroxaban Intermediate
Inombolo ye-CAS	161596-47-0
Inombolo yeCAT	I-RF-PI128
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C11H9NO3
Isisindo samangqamuzana	203.19
I-Melting Point	102℃
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Emhlophe Kuya Kumhlophe
Ukuhlonza	I-HPLC
Ukulahlekelwa Ekumisweni	≤0.50%
I-Sulfate Ash	≤0.50%
Ukuhlanzeka / Indlela Yokuhlaziya	≥98.0% (HPLC)
I-Phthalimide	≤0.10%
I-Single Max Ukungcola	≤0.50%
Ukungcola Okuphelele	≤2.0%
I-Epichlorohydrin	≤0.10%
IGlycidol	≤0.10%
I-Chiral Purity	I-R-isomer ≤2.0% (HPLC)
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Rivaroxaban (CAS: 366789-02-8) Phakathi

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Synthesis Route

Iphakheji nesitoreji:

Izinzuzo:

I-FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomphakeli we-(S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) enekhwalithi ephezulu.Kuyinto ephakathi ngokuvamile ekuhlanganiseni kwe-Rivaroxaban (CAS: 366789-02-8), ekwelapheni i-Venous Thromboembolism (VTE).

I-Rivaroxaban (Xarelto; CAS: 366789-02-8) iyisidakamizwa se-antithrombotic futhi yathuthukiswa ngokubambisana phakathi kwenkampani yaseJalimane i-Bayer Pharmaceuticals ne-American Johnson.I-Rivaroxaban iboniswa ekwelapheni i-vein thrombosis ejulile kanye ne-pulmonary embolism, nokuvimbela i-thrombosis ejulile ye-vein thrombosis kanye ne-pulmonary embolism kubantu abadala.